Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 7
2004 13
2005 10
2006 8
2007 5
2008 7
2009 7
2010 6
2011 7
2012 8
2013 8
2014 9
2015 2
2016 4
2017 5
2018 2
2019 3
2020 1
2021 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
NUP98::Nsd1 and FLT3-ITD collaborate to generate acute myeloid leukemia.
Matsukawa T, Yin M, Nigam N, Negi V, Li L, Small D, Zhu YJ, Walker RL, Meltzer PS, Aplan PD. Matsukawa T, et al. Among authors: small d. Leukemia. 2023 Jul;37(7):1545-1548. doi: 10.1038/s41375-023-01913-0. Epub 2023 May 5. Leukemia. 2023. PMID: 37147424 Free PMC article. No abstract available.
DOCK2: A novel FLT3/ITD leukemia drug target.
Wu M, Small D, Duffield AS. Wu M, et al. Among authors: small d. Oncotarget. 2017 Sep 30;8(51):88253-88254. doi: 10.18632/oncotarget.21390. eCollection 2017 Oct 24. Oncotarget. 2017. PMID: 29179430 Free PMC article. No abstract available.
Small molecule FLT3 tyrosine kinase inhibitors.
Levis M, Small D. Levis M, et al. Among authors: small d. Curr Pharm Des. 2004;10(11):1183-93. doi: 10.2174/1381612043452604. Curr Pharm Des. 2004. PMID: 15078134 Review.
FLT3 tyrosine kinase inhibitors.
Levis M, Small D. Levis M, et al. Among authors: small d. Int J Hematol. 2005 Aug;82(2):100-7. doi: 10.1532/IJH97.05079. Int J Hematol. 2005. PMID: 16146839 Review.
Kinase inhibitors in leukemia.
Levis M, Small D. Levis M, et al. Among authors: small d. Adv Pharmacol. 2004;51:1-33. doi: 10.1016/S1054-3589(04)51001-3. Adv Pharmacol. 2004. PMID: 15464903 Review. No abstract available.
Mechanisms of resistance to FLT3 inhibitors.
Chu SH, Small D. Chu SH, et al. Among authors: small d. Drug Resist Updat. 2009 Feb-Apr;12(1-2):8-16. doi: 10.1016/j.drup.2008.12.001. Epub 2009 Jan 21. Drug Resist Updat. 2009. PMID: 19162530 Free PMC article. Review.
Novel FLT3 tyrosine kinase inhibitors.
Levis M, Small D. Levis M, et al. Among authors: small d. Expert Opin Investig Drugs. 2003 Dec;12(12):1951-62. doi: 10.1517/13543784.12.12.1951. Expert Opin Investig Drugs. 2003. PMID: 14640939 Review.
FLT3 mutations: biology and treatment.
Small D. Small D. Hematology Am Soc Hematol Educ Program. 2006:178-84. doi: 10.1182/asheducation-2006.1.178. Hematology Am Soc Hematol Educ Program. 2006. PMID: 17124058 Review.
Targeting FLT3 for the treatment of leukemia.
Small D. Small D. Semin Hematol. 2008 Jul;45(3 Suppl 2):S17-21. doi: 10.1053/j.seminhematol.2008.07.007. Semin Hematol. 2008. PMID: 18760705 Free PMC article. Review.
105 results